Advertisement
Novara — A Smarter Way to Access Global Markets
LIVE DESK·Global markets desk

US Dollar / Japanese Yen

USDJPY
156.6985▼ 0.34%
As of 27/09/2026, 21:00:00

Overview

Open157.2300
Day Range156.47901 – 157.85153
52-Week Range146.58 – 164.08805
Volume—

Related News

The Retail Trading Boom: How Everyday Traders Reshaped the Industry
ForexArticle

The Retail Trading Boom: How Everyday Traders Reshaped the Industry

Two decades ago, forex and CFD trading were largely inaccessible to individual investors, requiring institutional connections, dedicated infrastructure, and significant capital just to open an account. Today, opening a…

How Central Bank Decisions Move Currency Markets
ForexArticle

How Central Bank Decisions Move Currency Markets

Central banks are among the most influential forces in the forex market. Interest rate decisions, in particular, can trigger significant currency volatility within seconds of an announcement, as traders rapidly reprice…

Dollar hits two-month high as Swiss franc, yen weaken on hawkish Fed outlook
ForexArticle

Dollar hits two-month high as Swiss franc, yen weaken on hawkish Fed outlook

The dollar rose 0.14% to 101.27 for a fourth straight daily advance, pressing the franc to its lowest level since May 2025, as Fed officials opened the door to further rate increases.

Swiss franc rallies as USD/CHF drops below 0.8200, SNB warns of FX intervention
ForexArticle

Swiss franc rallies as USD/CHF drops below 0.8200, SNB warns of FX intervention

The Swiss franc strengthened against the dollar, with the pair slipping below 0.8200, while the SNB signaled readiness to intervene amid heightened Middle East risk.

Euro falls to $1.145 as oil rises and German political turmoil weighs
ForexArticle

Euro falls to $1.145 as oil rises and German political turmoil weighs

The euro slipped to $1.145, its lowest since late July, amid higher Brent crude prices and mounting political risk after the CDU’s defeats in German state elections.

EU Approves Roche’s Susvimo for Neovascular AMD Treatment
ForexArticle

EU Approves Roche’s Susvimo for Neovascular AMD Treatment

The European Commission has granted marketing authorization for Roche’s implant-based Susvimo, marking the first continuous-delivery option for neovascular age-related macular degeneration.